跳至主要内容
临床试验/NL-OMON48331
NL-OMON48331招募中不适用

Fasting tolerance in patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD) in the first six months of life: an investigator-initiated human pilot-study. - *FiTtINg MCADD*: Fasting Tolerance In MCADD-infants.

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • 1. Age below 6 months of life. In case of premature births, the child may be included and treated according to the corrected age.;2. Established MCADD diagnosis. The diagnosis should be confirmed by a combination of (a) NBS outcome (b) MCAD enzyme activity measured with phenylpropionyl-CoA as a substrate, ideally in lymphocytes (considered to be the golden standard) and (c) ACADM gene mutation analysis.

排除标准

  • Any other chronic and/or genetic condition that is deemed an exclusion criterion based on the judgement of the treating metabolic paediatrician or investigators.

研究者

相似试验